A phase 3 trial of a higher-dose CagriSema formulation at 2.4/7.2 mg is planned for initiation in the second half of 2026, and the REDEFINE 11 trial, exploring CagriSemas full weight-loss potential, is expected to report data in the first half of 2027
A 2019 review found that L-carnitine significantly reduced diastolic blood pressure, especially in people with overweight or obesity
We previously showed the presence of mitochondrial dysfunction as early as P15 in the motor cortex, but more precisely in the CSMN of TDP-43 A315T mice 17 , one of the best characterized mouse models of TDP-43 pathology 16,19,33,34
If you suspect you might have a B12 deficiency, the best place to start is with a medical evaluation
Here are some ways employers can strike that balance
Occasional injection site reactions occur in 5-10% of patients but resolve quickly